Royal Philips (NYSE: PHG; AEX: PHI) today announced the launch of EmboGuide, its latest innovation in interventional oncology, to treat difficult-to-reach tumors or tumors in patients who are deemed unsuitable for surgery.
Share the Post
About the Author
Philips Respironics, a global leader in the sleep and respiratory markets, is passionate about providing solutions that lead to healthier patients, healthier practices, and healthier businesses. For us, innovation is driven by gaining insight into the needs of the people who use our products in the areas of sleep apnea management, oxygen therapy, noninvasive ventilation and respiratory drug delivery.